A Long-Term Safety Study of OZURDEX® in Clinical Practice
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This study is a multicenter, prospective, observational study to evaluate the long-term
safety of OZURDEX® in patients with macular oedema following central retinal vein occlusion
(CRVO) or branch retinal vein occlusion (BRVO) or patients with non-infectious posterior
segment uveitis in real-world clinical practice.